W3C home > Mailing lists > Public > public-semweb-lifesci@w3.org > March 2013

Re: [Update] Clinical Pharmacogenomics: RxNorm *** UPDATED ***

From: Olivier Bodenreider <olivier@nlm.nih.gov>
Date: Wed, 6 Mar 2013 14:17:12 -0500
Message-ID: <51379638.9070306@nlm.nih.gov>
To: Alan Ruttenberg <alanruttenberg@gmail.com>
CC: "w3.hcls@gmail.com" <w3.hcls@gmail.com>, "public-semweb-lifesci@w3.org" <public-semweb-lifesci@w3.org>
There is crucial negation missing from my earlier post. Apologies.

In practice, creating an RDF version the the content in 1) above would 
*NOT* violate the UMLS license agreement, as long as NLM is acknowledged 
as the provider of the data.

-----

Quick clarification.
RxNorm is several things in one box.
1) Everything tagged with the provenance SAB=RXNORM belongs to NLM and 
is publicly available. This includes at least one normalized name and 
code ("RxCUI") for each drug entity in scope. It also includes the 
majority on NDCs.
2) Content integrated from a dozen external sources, with various 
intellectual property restrictions (e.g., First DataBank). This content 
is tagged with SAB=XXX (XXX != RXNORM) and may be restricted, according 
to the terms of UMLS license agreement.
In practice, creating an RDF version the the content in 1) above would 
*NOT* violate the UMLS license agreement, as long as NLM is acknowledged 
as the provider of the data. (This is in the same spirit the SAB=RXNORM 
information is made available by NLM through RxNav and the RxNorm API 
[http://rxnav.nlm.nih.gov/] without requiring UMLS credentials.)
Of course, versioning should be clearly labeled, as RxNorm is updated 
weekly.
Hope this helps.


-- 
Dr. Olivier Bodenreider
Senior Scientist
Chief, Cognitive Science Branch
National Library of Medicine
8600 Rockville Pike - MS 3826 (Bldg 38A, Rm 9S904)
Bethesda, MD 20894 - USA
office: 301 435-3246 - cell: 240 271-3195 - fax: 301 496-0673


On 03/06/2013 12:00 PM, Alan Ruttenberg wrote:
> Will there be anybody discussing the license issues, which seem to
> disallow this kind of dissemination?
>
> -Alan
>
> On Tue, Mar 5, 2013 at 1:31 PM, w3.hcls@gmail.com
> <mailto:w3.hcls@gmail.com> <w3.hcls@gmail.com
> <mailto:w3.hcls@gmail.com>> wrote:
>
>     Tomorrow's clinical pharmacogenomics call will center around RxNorm.
>     Janos Hajagos will discuss his approach to converting RxNorm to RDF,
>     and we'll discuss how to get this into Bio2RDF for everybody.
>
>
>           Clinical Pharmacogenomics
>
>     Dial-In #: +1.617.761.6200 <tel:%2B1.617.761.6200> (Cambridge, MA)
>     VoIP address: sip:zakim@voip.w3.org <mailto:sip%3Azakim@voip.w3.org>
>     Participant Access Code: 4257 ("HCLS")
>     IRC: irc.w3.org
>     <http://www.google.com/url?q=http%3A%2F%2Firc.w3.org&usd=2&usg=AFQjCNHOBGoZ3XRTiMjzoQ3Q49-aDyDa3g>
>     port 6665 channel #HCLS
>     Duration: ~1 hour
>     Frequency: 1st and 3rd Wednesday
>     Convener: Michel Dumontier & Matthias Samwald
>     /When/
>     	________Wed 2013-03-06 10:15 – 11:15 Eastern Time
>     /Who/
>     	
>     •	
>     Health Care Life Sciences- organizer
>     •	
>     public-semweb-lifesci@w3.org <mailto:public-semweb-lifesci@w3.org>
>
>
Received on Wednesday, 6 March 2013 19:19:00 UTC

This archive was generated by hypermail 2.3.1 : Wednesday, 7 January 2015 14:53:01 UTC